Performance diagnostique de la PCR Mucorales spp. dans les prélèvements respiratoires profonds : une étude rétrospective monocentrique
Year: 2023
Type: dissertation
Study design: Observational Study
Abstract: Mucormycosis is the 4th invasive fungal infection reported in France. The prognosis is determined by the rapid initiation of an antifungal agent. Serum Mucorales PCR has shown excellent diagnostic performance. Its performance needs to be evaluated in deep respiratory specimens. The objective was to estimate the performance of Mucorales PCR in broncho-alveolar lavage (BAL). A single-center retrospective study including patients born before 2004 (> 18 years) who had Mucorales PCR between January 2021 and May 2022 on BAL was designed. Diagnosis was made by an adjudication committee (gold-standard) and then classified according to EORTC criteria. We used the MycoGENIE® PCR kit (Ademtech). 938 patients had Mucorales PCR in BAL and were included. It was positive for 21/938 patients (2.2%). Among the real cases (n=11), 2 (18.2%) were proven mucormycosis, 2 (18.2%) probable, 7 possible (63.6%) according to EORTC. The main host criterion was a hematologic malignancy for 10/11 (90.9%). Blood PCR was positive in 72.7% of cases (n = 8). Three patients had a positive PCR in BAL but negative in blood. The sensitivity of the Mucorales PCR was estimated at 72.7% (IC95 43.4-90.3) and the specificity at 98.6% (IC95 97.6-99.2%). The PPV was 38.1% (IC95 20.8-59.1%) and the NPV was 99.7% (IC 95 99.1-99.9%). The low PPV confirms that a positive result should be interpreted with caution given the possible carriage of Mucorales in the airways. However, its high NPV and specificity make it a relevant tool in the diagnostic strategy of pulmonary mucormycosis.
Source: HAL
Author: Brousse, Xavier, Martin
Institution: Université de Bordeaux
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W6995762001
